Westaim (OTCMKTS:WEDXF) vs. ASP Isotopes (NASDAQ:ASPI) Financial Comparison

Westaim (OTCMKTS:WEDXF) and ASP Isotopes (NASDAQ:ASPI) are both small-cap materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Valuation & Earnings

This table compares Westaim and ASP Isotopes”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Westaim	$53.37 million	8.86	-$38.00 million	($1.92)	-7.40
ASP Isotopes	$30.85 million	19.88	-$175.09 million	($1.32)	-3.03

Westaim has higher revenue and earnings than ASP Isotopes. Westaim is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Westaim and ASP Isotopes’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Westaim	-108.56%	-9.68%	-7.67%
ASP Isotopes	-427.98%	-64.99%	-32.20%

Analyst Ratings

This is a summary of recent recommendations for Westaim and ASP Isotopes, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Westaim	0	0	0	0	0.00
ASP Isotopes	1	0	2	0	2.33

ASP Isotopes has a consensus target price of $13.00, suggesting a potential upside of 225.00%. Given ASP Isotopes’ stronger consensus rating and higher probable upside, analysts plainly believe ASP Isotopes is more favorable than Westaim.

Insider and Institutional Ownership

16.8% of ASP Isotopes shares are owned by institutional investors. 4.2% of Westaim shares are owned by insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Westaim has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.61, indicating that its share price is 261% more volatile than the S&P 500.

Summary

ASP Isotopes beats Westaim on 9 of the 14 factors compared between the two stocks.

About Westaim

The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.